Can the Femoral Nerve Block be Improved by Ultrasound Guidance?

June 11, 2008 updated by: NHS Greater Glasgow and Clyde

Can the Use of Ultrasound to Guide the Insertion of a Needle for an Anterior Psoas Compartment Nerve Block Increase Its Efficacy in Comparison to Traditional Techniques Utilising Loss of Resistance and Nerve Stimulation?

Studies have suggested a link with effective pain relief and reduced illness and death in very unwell patients. This study will determine the most effective method of injecting local anaesthetic around the nerves which supply the hip joint. Local anaesthetic will be injected around the hips nerve supply using either ultrasound, loss of resistance or electrical nerve stimulator to guide the positioning of the needle on patients due for elective total hip replacement. The patient will then be observed for 30 minutes and the patient ability to move or feel the upper leg will recorded. A standard anaesthetic and a hip replacement operation will then be performed. Standard pain relief protocols will be used the operation and after the operation. After the operation we will record the amount of morphine used and how happy the patients have been with their treatment at 6 hours after the operation and at 24 hours after the operation. The first day the patient is able to walk on their new hip replacement will also be recorded.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

269

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Lanarkshire
      • Glasgow, Lanarkshire, United Kingdom, G12 0YN
        • Gartnavel General Hospital
      • Glasgow, Lanarkshire, United Kingdom, G4
        • Glasgow Royal Infrimary
      • Glasgow, Lanarkshire, United Kingdom
        • Golden Jubilee Hospital
    • Renfrewshire
      • Paisley, Renfrewshire, United Kingdom, PA2
        • Royal Alexandra Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Elective primary total hip arthroplasty under general anaesthesia
  • ASA<=4
  • Able to give informed consent
  • Able to cooperate with sensory and motor testing of lower limb function

Exclusion Criteria:

  • Abnormal clotting screen (coagulopathy) or thrombocytopenia (<100,000)
  • Acute mental test score of <=7 at any time pre or post operatively
  • Allergy to local anaesthetic
  • Signs, symptoms or laboratory evidence of local infection or systemic sepsis
  • No pre-existing neurological deficit (sensory or motor) affecting lower limb
  • Patients with lower limb amputations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: loss of resistance
Anterior psoas compartment nerve block inserted using loss of resistance
Use of ultrasound to guide the insertion of anterior psoas compartment block
Active Comparator: nerve stimulator
Anterior psoas compartment nerve block inserted using nerve stimulator
Use of ultrasound to guide the insertion of anterior psoas compartment block
The use of the nerve stimulator to guide insertion of the anterior psoas compartment block
Active Comparator: ultrasound
Anterior psoas compartment nerve block inserted using ultrasound
Use of ultrasound to guide the insertion of anterior psoas compartment block

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
percentage of patients with effective regional analgesia
Time Frame: Induction of anaesthesia
Induction of anaesthesia

Secondary Outcome Measures

Outcome Measure
Time Frame
hospital mortality
Time Frame: 1months after operation
1months after operation
sensory function in lateral cutaneous nerve
Time Frame: 0mins, 10mins 20mins post insertion of local anaesthetic
0mins, 10mins 20mins post insertion of local anaesthetic
sensory function of femoral nerve
Time Frame: 0mins, 10mins, 20mins after insertion of local anesthetic
0mins, 10mins, 20mins after insertion of local anesthetic
sensory function of obturator nerve
Time Frame: 0mins, 10mins, 20mins after insertion of local anesthetic
0mins, 10mins, 20mins after insertion of local anesthetic
motor function of obturator nerve
Time Frame: 0mins, 10mins and 20minutes after insrtion of local anesthetic
0mins, 10mins and 20minutes after insrtion of local anesthetic
motor function of femoral nerve
Time Frame: 0mins,10mins and 20mins post insertion of local anesthetic
0mins,10mins and 20mins post insertion of local anesthetic
acute mental test scores
Time Frame: 6hours and 24 hours post operatively
6hours and 24 hours post operatively
total morphine dose administered
Time Frame: 6hours and 24 hours post operstively
6hours and 24 hours post operstively
day first mobilise post operatively
Time Frame: post operatively 0-10 days
post operatively 0-10 days
patient satisfaction scores
Time Frame: 6 hours and 24hours post operatively
6 hours and 24hours post operatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Malcolm watson, MB ChB FRCA, NHS Greater Glasgow and Clyde

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2008

Primary Completion (Anticipated)

July 1, 2010

Study Completion (Anticipated)

August 1, 2010

Study Registration Dates

First Submitted

June 9, 2008

First Submitted That Met QC Criteria

June 11, 2008

First Posted (Estimate)

June 12, 2008

Study Record Updates

Last Update Posted (Estimate)

June 12, 2008

Last Update Submitted That Met QC Criteria

June 11, 2008

Last Verified

June 1, 2008

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ultrasound for hip # study-1
  • CSO reference CAF/07/05

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe